By contrast, the dominant company would be the only one marketing the tablet version of Losec. See Linklaters, “EU Court upholds ‘novel’ approach to abuse of dominance in pivotal pharma appeal”, online publication, 1 July 2010 (available at http://www.linklaters.com/Publications/201007013/Pages/Index.aspx). Box 9 briefly explains the EU’s approach to examining market dominance.